Product NDC: | 17478-705 |
Proprietary Name: | Betaxolol |
Non Proprietary Name: | Betaxolol Hydrochloride |
Active Ingredient(s): | 5 mg/mL & nbsp; Betaxolol Hydrochloride |
Administration Route(s): | OPHTHALMIC |
Dosage Form(s): | SOLUTION/ DROPS |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 17478-705 |
Labeler Name: | Akorn, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA075386 |
Marketing Category: | ANDA |
Start Marketing Date: | 20030401 |
Package NDC: | 17478-705-12 |
Package Description: | 1 VIAL in 1 CARTON (17478-705-12) > 15 mL in 1 VIAL |
NDC Code | 17478-705-12 |
Proprietary Name | Betaxolol |
Package Description | 1 VIAL in 1 CARTON (17478-705-12) > 15 mL in 1 VIAL |
Product NDC | 17478-705 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Betaxolol Hydrochloride |
Dosage Form Name | SOLUTION/ DROPS |
Route Name | OPHTHALMIC |
Start Marketing Date | 20030401 |
Marketing Category Name | ANDA |
Labeler Name | Akorn, Inc. |
Substance Name | BETAXOLOL HYDROCHLORIDE |
Strength Number | 5 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC] |